GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
82 hedge funds and large institutions have $381M invested in GenMark Diagnostics, Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 8 closing their positions.
2,200% more call options, than puts
Call options by funds: $23K | Put options by funds: $1K
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
5% more funds holding
Funds holding: 78 → 82 (+4)
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
0.56% more ownership
Funds ownership: 101.1% → 101.66% (+0.56%)
33% less capital invested
Capital invested by funds: $571M → $381M (-$190M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$10.8M |
| 2 |
Millennium Management
New York
|
+$3.37M |
| 3 |
JP Morgan Chase
New York
|
+$2.38M |
| 4 |
Asset Management One
Tokyo,
Japan
|
+$1.36M |
| 5 |
Jennison Associates
New York
|
+$932K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
-$8.03M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$4.82M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.83M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$2.03M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$957K |
GNMK Hedge Fund Activity: Q3 2014 in Review
82 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2014, worth a combined $381M — down 33% from $571M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GNMK positions and 8 closed out — a net gain of 4 holders — while 25 added to existing stakes and 23 trimmed.
The largest buyer was Putnam Investments, adding an estimated $10.8M. The largest seller was Parnassus Investments, cutting an estimated $8.03M.
- 82 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2014, up from 78 in Q2 2014.
- Funds reported $381M of GenMark Diagnostics, Inc stock for Q3 2014, down 33% quarter-over-quarter.
- 12 funds opened new GenMark Diagnostics, Inc positions in Q3 2014 and 8 closed out, a net change of +4 holders.
- The largest GenMark Diagnostics, Inc buyer in Q3 2014 was Putnam Investments, an estimated $10.8M added.
- The largest GenMark Diagnostics, Inc seller in Q3 2014 was Parnassus Investments, an estimated $8.03M sold.
Based on aggregated 13F filings for Q3 2014.